Literature DB >> 16962751

Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.

Giuseppina Sandri1, Maria Cristina Bonferoni, Silvia Rossi, Franca Ferrari, Sara Gibin, Ylenia Zambito, Giacomo Di Colo, Carla Caramella.   

Abstract

Among the chitosan derivatives, trimethylchitosan (TMC) has been shown to have penetration enhancement properties also in intestinal environment. In addition, the use of nanoparticulate systems has the advantage of protecting peptidic drugs from intestinal degradations, due to internalisation behaviour. Therefore, the aim of this paper was to evaluate nanoparticulate systems based on TMC. In particular the mucoadhesive and absorption enhancement properties of nanoparticles based on TMC with different quaternization degree (QD) intended for the intestinal administration of macromolecules (peptides) have been evaluated. Comparison with chitosan (CS.HCl) nanoparticles was made. The nanoparticles were loaded with fluorescein isothiocyanate dextran (FD4, MW 4400 Da), used as the model macromolecule. The intestinal penetration enhancement properties of nanoparticles were investigated in an in vitro Caco-2 cell model and an ex vivo rat jejunum model. The mucoadhesion of the nanosystems was evaluated using excised rat jejunum. All of the nanoparticulate systems interacted with the Caco-2 cells decreasing the transepithelial electric resistance (TEER) and increasing Lucifer Yellow (LY) Papp (paracellular pathway marker). All the nanosystems improved FD4 Papp, with the exception of the nanoparticles based on TMC with the highest QD. In this case an entrapment of nanoparticles into Caco-2 cells was supposed. Analogous results were obtained using the excised rat jejunum model. The increase in QD of TMC was seen to favour the mucoadhesion, resulting in a prolonged residence time on intestinal mucosa. The nanoparticle penetration into excised rat jejunum tissue, observed by means of CLSM, suggested that the mucoadhesive properties delayed the absorption of nanoparticles, however they produced an increase in the contact time with intestinal epithelium, offering a better chance for internalisation. The improvement of mucoadhesion and of nanoparticle internalisation with respect to chitosan nanosystems makes the TMCs nanosystems suitable carriers for the intestinal absorption of peptides.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16962751     DOI: 10.1016/j.ejpb.2006.07.016

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  20 in total

1.  Insulin-loaded nanoparticles based on N-trimethyl chitosan: in vitro (Caco-2 model) and ex vivo (excised rat jejunum, duodenum, and ileum) evaluation of penetration enhancement properties.

Authors:  Giuseppina Sandri; Maria Cristina Bonferoni; Silvia Rossi; Franca Ferrari; Cinzia Boselli; Carla Caramella
Journal:  AAPS PharmSciTech       Date:  2010-03-16       Impact factor: 3.246

Review 2.  Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.

Authors:  Anumita Chaudhury; Surajit Das
Journal:  AAPS PharmSciTech       Date:  2010-12-11       Impact factor: 3.246

3.  Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin.

Authors:  Pedro Fonte; Tiago Nogueira; Christiane Gehm; Domingos Ferreira; Bruno Sarmento
Journal:  Drug Deliv Transl Res       Date:  2011-08       Impact factor: 4.617

4.  Preparation, statistical optimization, and in vitro characterization of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan.

Authors:  Reza Mahjub; Farid Abedin Dorkoosh; Mohsen Amini; Mohammad Reza Khoshayand; Morteza Rafiee-Tehrani
Journal:  AAPS PharmSciTech       Date:  2011-10-27       Impact factor: 3.246

5.  Chitosan and glyceryl monooleate nanostructures containing gemcitabine: potential delivery system for pancreatic cancer treatment.

Authors:  William J Trickler; Jatin Khurana; Ankita A Nagvekar; Alekha K Dash
Journal:  AAPS PharmSciTech       Date:  2010-03-18       Impact factor: 3.246

6.  Investigation of polymeric amphiphilic nanoparticles as antitumor drug carriers.

Authors:  Jing Zhang; Xi Guang Chen; Cheng Sheng Liu; Hyun Jin Park
Journal:  J Mater Sci Mater Med       Date:  2008-12-13       Impact factor: 3.896

7.  The in vitro sub-cellular localization and in vivo efficacy of novel chitosan/GMO nanostructures containing paclitaxel.

Authors:  W J Trickler; A A Nagvekar; A K Dash
Journal:  Pharm Res       Date:  2009-05-20       Impact factor: 4.200

8.  A novel nanoparticle formulation for sustained paclitaxel delivery.

Authors:  W J Trickler; A A Nagvekar; A K Dash
Journal:  AAPS PharmSciTech       Date:  2008-03-18       Impact factor: 3.246

Review 9.  Trimethyl chitosan and its applications in drug delivery.

Authors:  V K Mourya; Nazma N Inamdar
Journal:  J Mater Sci Mater Med       Date:  2008-12-27       Impact factor: 3.896

10.  The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromolecules.

Authors:  Benjamin A Teply; Rong Tong; Seok Y Jeong; Gaurav Luther; Ines Sherifi; Christopher H Yim; Ali Khademhosseini; Omid C Farokhzad; Robert S Langer; Jianjun Cheng
Journal:  Biomaterials       Date:  2007-12-21       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.